Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2870279017 | Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unit/3.5mg/10000unit ophthalmic ointment (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2870696014 | Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unit/3.5mg/10000unit ophthalmic ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2870697017 | Bacitracin zinc + neomycin sulphate + polymyxin b sulphate 400unit/3.5mg/10000unit ophthalmic ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3209391000052119 | bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Is a | Product containing neomycin (medicinal product) | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Is a | Bacitracin-containing product in ocular dose form | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Is a | Compound neomycin preparations | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Is a | neomycin för lokalt bruk | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has active ingredient | Topical neomycin | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has active ingredient | Bacitracin ophthalmic preparation | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Is a | bacitracinzink + neomycinsulfat + polymyxin B-sulfat | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has active ingredient | Polymyxin B sulfate (substance) | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has active ingredient | antiinfektivt medel för huden | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has active ingredient | Zinc bacitracin | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has active ingredient | Neomycin sulfate | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Is a | neomycin för oftalmiskt bruk | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Is a | polymyxin B, ögonsalva | false | Inferred relationship | Some | ||
| bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has manufactured dose form | Eye ointment | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR